Class IICompleted

Lisdexamfetamine Dimesylate Capsules recall

FDA recall D-0599-2025 · initiated Aug 11, 2025

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.

Details

Product: Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37
Recalling company: Lannett
Classification: Class II
Status: Completed
Type: Voluntary: Firm initiated
Distribution: Nationwide within the USA
Initiated: Aug 11, 2025
FDA report date: Sep 3, 2025

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0599-2025 ↗

← All drug recalls